Mike Nicholds is a highly accomplished executive with decades of experience in the biotechnology, electronics, and chemical industries. He has gained extensive board and senior-level achievement in B2B companies that cater to global clients in the pharmaceutical, biotechnology, agrochemical, and electronic sectors. Nicholds has a robust skill set that includes strategy development and implementation, international business development, non-executive and executive board experience, acquisition and licensing, fund raising, and start-up and technology commercialization.

Nicholds has studied Doctor of Philosophy (PhD) in Microbiology from the University of London and holds a Bsc(Hons); Ph.D in Microbiology and Fermentation from King's College London.

He is currently the Chief Executive Officer at Newcells Biotech Ltd and has previously served as a Member Board of Trustees at Dementia Care, Managing Director at Cels Business Services Ltd (CBSL), Director - Bionow at Cels Ltd trading as Bionow, Commercial Director at Avecia Biotechnology, Business Development Director at Avecia Inkjet Printing Materials, VP Sales and Marketing at Chirex, and Strategy and Acquisitions Director at Zeneca LifeScience Molecules.